DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Grillo-Lopez AJ.
90Y-ibritumomab tiuxetan: rationale for patient selection in the treatment of indolent non-Hodgkin’s lymphoma.
Semin Oncol 2005; 32 (suppl 1) S44-S49
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.